LEADER 03809nam 22006615 450 001 9910300074203321 005 20200704223707.0 010 $a3-642-38850-7 024 7 $a10.1007/978-3-642-38850-7 035 $a(CKB)3710000000025223 035 $a(EBL)1466318 035 $a(OCoLC)862048954 035 $a(SSID)ssj0001049410 035 $a(PQKBManifestationID)11602415 035 $a(PQKBTitleCode)TC0001049410 035 $a(PQKBWorkID)11019563 035 $a(PQKB)10171372 035 $a(MiAaPQ)EBC1466318 035 $a(DE-He213)978-3-642-38850-7 035 $a(PPN)176112820 035 $a(EXLCZ)993710000000025223 100 $a20131004d2014 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCytopathology in Oncology /$fedited by Ritu Nayar 205 $a1st ed. 2014. 210 1$aBerlin, Heidelberg :$cSpringer Berlin Heidelberg :$cImprint: Springer,$d2014. 215 $a1 online resource (287 p.) 225 1 $aCancer Treatment and Research,$x0927-3042 ;$v160 300 $aDescription based upon print version of record. 311 $a3-642-38849-3 320 $aIncludes bibliographical references. 327 $aOverview of Cytopathology Procedures and Techniques -- Ancillary Studies on Neoplastic Cytologic Specimens -- Head and Neck -- Cytology of the Lung -- Liver Cytology -- Esophagus, Stomach, and Pancreas -- Genitourinary Cytopathology (Kidney and Urinary Tract) -- Body Cavity Fluids -- Cytopathology in the Diagnosis of Lymphoma -- Female Genital Tract -- Beyond the Standard of Care: The Role of Cytopathology in Molecular Testing of Cancer. 330 $aIn recent decades, cytopathology has assumed an increasing role in the primary diagnosis of mass lesions owing to its ability to provide rapid, non-invasive, and timely information. With cytopathology at the forefront of diagnosis and prognostication of neoplastic lesions, it is essential that physicians involved in the diagnosis and treatment of precancerous lesions and cancer have a clear understanding of specimen collection techniques, terminology for reporting, and outcomes in various diagnostic categories. This book provides a comprehensive overview of the role of cytology at various body sites. The diagnostic details covered are abbreviated in comparison with those in pathology texts. Instead, a more clinical approach is taken, with the focus on the advantages and limitations of techniques and the key features of entities that are important to clinicians. Pathological?clinical correlation is highlighted throughout the book, ensuring that it will be highly relevant for clinicians. In particular, physicians who deal with oncology patients will find it to be a rich source of guidance on how to use and understand cytopathology in the diagnosis and exclusion of malignancy. 410 0$aCancer Treatment and Research,$x0927-3042 ;$v160 606 $aOncology   606 $aPathology 606 $aMedicine 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aPathology$3https://scigraph.springernature.com/ontologies/product-market-codes/H4800X 606 $aMedicine/Public Health, general$3https://scigraph.springernature.com/ontologies/product-market-codes/H00007 615 0$aOncology  . 615 0$aPathology. 615 0$aMedicine. 615 14$aOncology. 615 24$aPathology. 615 24$aMedicine/Public Health, general. 676 $a611 676 $a611/.01815 676 $a616.99407582 702 $aNayar$b Ritu$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300074203321 996 $aCytopathology in Oncology$91522338 997 $aUNINA